Guillaume Butler-Laporte

I use a wide variety of omic technologies (sequencing, proteomic, HLA typing, etc) in large-scale biobanks to solve problems that lead to actionable clinical discoveries. To do this, the lab applies and develops genetic epidemiology methods that use genetic variants as anchors with which to perform causal inference. This is important, as causal associations are more likely to lead to clinical targets. While as a clinician I am an infectious diseases specialist, my genetics interest are broader, and I support any research program focused on translating multi-omics and genetics to better patient care. Feel free to reach out with any questions